Richard Saynor
@SaynorRichardExperienced and enthusiastic leader; loves pioneering access for patients and driving innovation in classic & established medicines. CEO @Sandoz_Global
Similar User
@HHSvaccines
@Novartis_CH
@FinEmbTallinn
@ChrPawlu
@dgarciaazorin
@Julie_MarJam
@M_AntoniaMira
@Jaipal81710973
@GbDeanR
Today marks the start of this year’s World Antimicrobial Awareness Week. Read my latest article on busting some myths around drug resistance: linkedin.com/pulse/frogs-su…
We have to get away from the simplistic belief that R&D will produce a ‘silver bullet’ to magically end #AMR, because every new drug will in time also be subject to resistance. 🙏 Thanks to everyone for joining #AntimicrobialResistance2021
#AntimicrobialResistance2021 launches inside the @newscientist on 25/11 and online today at ow.ly/uxPs30s0TuM featuring Sonita Chada-Grathwol, Ph.D with @NovartisUK #WAAW #AMR
We are proud to be recognized by @genericsbulletin for the #RegulatoryAchievement as well as the #Acquisition of the Year. A big thank you to all our associates for their continued hard work and passion to pioneer access for patients! #GGBAwards
The Award for Regulatory Achievement of the Year goes to… Sandoz! Congratulations on your well-deserved win! #GGBAwards
And the winner is Sandoz for the Acquisition of the Year award, sponsored by Adalvo, for their second win of the night! #GGBAwards
Thank you for the great discussion, @donatopmancini This yrs theme @ftlive conference is essential for us as leaders in healthcare industry. It was great to talk about the central role of #Biosimilars in resolving the pandemics longtail access crisis. #FTPharma @ft
“Patients are getting access to #biologics that they could never have even dreamt of just a few years ago”, said @SaynorRichard, CEO @Sandoz_Global in an interview w/ @donatopmancini at @ftlive conference. #FTPharma #biosimilars
Biosimilars have been around for 15 years in Europe and 5 in the US. Are we seeing the uptake we hoped for? What progress has been made to date in adding access, sustainability and savings to the healthcare system? #FTPharma book now: on.ft.com/3EYSkXz
Great news on how we continue our efforts to combat #COVID19. Since the onset of the pandemic #Sandoz has committed extensive breadth of potential treatment options & manufacturing resources to this global challenge. Proud to collaborate w/ @BioNTech_Group novartis.com/news/media-rel…
At #Sandoz we believe #antibiotics are the backbone of modern medicine & we are investing accordingly. Today, we are proud to announce the successful completion of our planned #acquisition of @GSK’s global cephalosporins portfolio. Read my thoughts: linkedin.com/pulse/bucking-…
#Sandoz is today proud to announce the successful completion of our planned #acquisition of @GSK’s global cephalosporins portfolio. Read our #PressRelease to find out more. #NovartisNews sandoz.com/news/media-rel…
I am happy to welcome Claire as the new Head of Global Product Development. I look forward to working with Claire to continue driving our purpose of pioneering access for patients worldwide. #sandoz #PioneeringAccessForPatients
We are excited to welcome Claire D'Abreu-Hayling as the new Head of Global Product Development. We look forward to her leadership as we continue to pioneer novel approaches to help patients worldwide access high-quality medicines.
Watch this discussion on stopping the silent pandemic: Ramping up action on antimicrobial resistance with @SaynorRichard @Sandoz_Global, and Lutz Hegemann @Novartis #DevexEvent @ #UNGA76 with @Novartis @NovartisGH #silentpandemic #globalhealth youtu.be/4phkoc04t6A
Thx for the discussion @JennyLeiRavelo As I never tire of pointing out antibiotics are the backbone of modern healthcare & we need to do everything we can to keep them that way-particularly given the growing threat of AMR which many call “silent pandemic” youtu.be/4phkoc04t6A
Looking forward to the discussion @Devex on why modern healthcare is almost unimaginable without functioning antibiotics why AMR poses a real & growing threat to their use & how we #Sandoz & @NovartisGH are joining forces w/ partners to do something about this before its too late
Join us as Lutz Hegemann, Head of Corporate Affairs & Global Health, @novartis, and Richard Saynor, CEO, @Sandoz_Global, discuss ramping up action against antimicrobial resistance. #DevexEvent @ #UNGA76 with @Novartis #silentpandemic #globalhealth #onehealth
Check out my latest article: Keeping healthcare sustainable: Let’s start by challenging the assumptions linkedin.com/pulse/keeping-… via @LinkedIn
Today, Sandoz has announced a binding agreement to acquire Aspen's Japanese business of off-patent medicines: sandoz.com/news/media-rel…
Check out my latest article: How to succeed in generics: It’s simple, but... linkedin.com/pulse/how-succ… via @LinkedIn
NEWS: Sandoz announces global deal to commercialize proposed key #MultipleSclerosis (#MS) #biosimilar medicine bddy.me/34imnXH #NovartisNews
Biosimilars are the “new generics” and more needs to be done in the US to help patients more fully benefit from them. Check out my perspective. #sandoz #biosimilars #makingaccesshappen linkedin.com/pulse/biosimil…
United States Trends
- 1. Bama 27 B posts
- 2. Auburn 15,8 B posts
- 3. Milroe 14,1 B posts
- 4. Oklahoma 41,4 B posts
- 5. #AEWFullGear 62,7 B posts
- 6. $CUTO 7.260 posts
- 7. Ryan Williams 3.175 posts
- 8. DeBoer 3.166 posts
- 9. Boomer Sooner 1.765 posts
- 10. #RollTide 3.377 posts
- 11. Vandy 6.619 posts
- 12. Marta 21,5 B posts
- 13. Saban 9.013 posts
- 14. Iowa State 5.657 posts
- 15. Lamelo 8.560 posts
- 16. Notre Dame 23,7 B posts
- 17. Big 12 2.271 posts
- 18. #NWSLChampionship 4.417 posts
- 19. Ospreay 4.842 posts
- 20. Thorne 2.660 posts
Something went wrong.
Something went wrong.